<DOC>
	<DOCNO>NCT00750230</DOCNO>
	<brief_summary>The purpose study evaluate use dietary supplement Natural Eggshell Membrane ( NEM ) treatment joint connective tissue discomfort , pain , flexibility .</brief_summary>
	<brief_title>Pilot Study Efficacy &amp; Safety Natural Eggshell Membrane ( NEM ) Joint &amp; Connective Tissue Disorders</brief_title>
	<detailed_description>It estimate 140 million adult U.S. suffer form joint connective tissue ( JCT ) disorder ( i.e . arthritis , lupus , gout , fibromyalgia , neck back pain , etc. ) . As population age , estimate expect grow rapidly . Traditional treatment disorder attempt address symptom ( pain , inflammation , discomfort ) associate disease . This usually involve use analgesic ( i.e . acetaminophen , oxycodone , propoxyphene ) non-steroidal anti-inflammatory drug ( NSAIDs ) ( i.e . ibuprofen , diclofenac , celecoxib ) , alone combination . Most treatment show limited effectiveness randomize controlled clinical trial ( RCTs ) know significant sometimes severe side effect . To avoid cardiac risk , gastrointestinal issue , dependency issue associate traditional JCT treatment ( particularly long-term use ) , many patient turn complementary alternative medicine ( CAMs ) dietary supplement . Glucosamine , chondroitin , methylsulfonylmethane ( MSM ) alone combination , widely market dietary supplement treat joint pain due osteoarthritis ( OA ) . Other vitamin , mineral , botanical kava , pine bark extract , capsicum , boswellia root extract , turmeric/curcumin , etc . also market various JCT pain malady . We present use eggshell membrane possible new natural therapeutic JCT disorder . A single center , open label human clinical study conduct evaluate efficacy safety NEMÂ® treatment pain inflexibility associate joint connective tissue disorder . Subjects take NEM , 500mg , daily 30 day . Subjects evaluate pain range motion .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<criteria>patient seek relief mild moderate pain due joint connective tissue ( JCT ) disorder . subject must persistent pain associate JCT disorder . subject require suspend current pain relief medication . Subjects currently take analgesic medication eligible participate study follow 14 day washout period NSAIDs , 7 day washout narcotic , 90 day washout injected steroid . subject currently take glucosamine , chondroitin sulfate MSM eligible 3month washout period . Patients exclude currently receive remissioninducing drug methotrexate immunosuppressive medication receive within past 3 month . body weight 250 pound great . know allergy egg egg product . pregnant breastfeed woman . subject previously enrol study evaluate pain relief within past 6 month currently involve research study involve investigational product ( drug , device , biologic ) new application approve product , within 30 day screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>arthritis</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>fibromyalgia</keyword>
	<keyword>connective tissue disorder</keyword>
</DOC>